Explore findings from the 2026 Cell and Gene Therapy Report on oncology adoption, emerging specialties, reimbursement and ...
NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...
InspiroGene™ by McKesson research across providers, payers, patients and advocates highlights persistent access barriers and explores how technology and AI could help close the gap Average number of ...
Keeping Care Connected: Closing Visibility Gaps in Specialty Pharmacy Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results